A detailed history of Tekla Capital Management LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Tekla Capital Management LLC holds 346,084 shares of GH stock, worth $10.1 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
346,084
Previous 472,184 26.71%
Holding current value
$10.1 Million
Previous $11.1 Million 11.95%
% of portfolio
0.49%
Previous 0.42%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

SELL
$20.94 - $38.01 $2.64 Million - $4.79 Million
-126,100 Reduced 26.71%
346,084 $12.4 Million
Q4 2022

Feb 10, 2023

BUY
$25.44 - $59.78 $3.21 Million - $7.54 Million
126,100 Added 36.44%
472,184 $12.8 Million
Q3 2022

Nov 01, 2022

SELL
$43.66 - $61.0 $235,763 - $329,400
-5,400 Reduced 1.54%
346,084 $18.6 Million
Q4 2021

Feb 14, 2022

SELL
$88.71 - $120.43 $3.24 Million - $4.4 Million
-36,500 Reduced 9.41%
351,484 $35.2 Million
Q3 2021

Nov 12, 2021

BUY
$98.77 - $132.17 $22.6 Million - $30.3 Million
229,257 Added 144.43%
387,984 $48.5 Million
Q1 2021

May 14, 2021

BUY
$127.04 - $179.1 $5.19 Million - $7.32 Million
40,875 Added 34.68%
158,727 $24.2 Million
Q3 2020

Nov 13, 2020

BUY
$80.32 - $111.8 $2.93 Million - $4.07 Million
36,430 Added 44.74%
117,852 $13.2 Million
Q2 2020

Aug 13, 2020

BUY
$60.49 - $97.5 $3.49 Million - $5.63 Million
57,766 Added 244.19%
81,422 $6.61 Million
Q1 2020

May 14, 2020

BUY
$59.04 - $88.81 $1.14 Million - $1.72 Million
19,323 Added 445.95%
23,656 $1.65 Million
Q4 2019

Feb 13, 2020

BUY
$59.49 - $82.78 $257,770 - $358,685
4,333 New
4,333 $339,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $2.98B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Tekla Capital Management LLC Portfolio

Follow Tekla Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.